These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17392412)

  • 1. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
    Ji G; Neugebauer V
    J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
    Ji G; Neugebauer V
    J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
    Fu Y; Neugebauer V
    J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
    Ji G; Fu Y; Adwanikar H; Neugebauer V
    Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    Pain; 2004 Jul; 110(1-2):112-22. PubMed ID: 15275758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala.
    Ji G; Fu Y; Ruppert KA; Neugebauer V
    Mol Pain; 2007 Jun; 3():13. PubMed ID: 17550594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    J Neurophysiol; 2006 Oct; 96(4):1803-15. PubMed ID: 16760343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons.
    Li W; Neugebauer V
    J Neurophysiol; 2004 Jan; 91(1):13-24. PubMed ID: 13679408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
    J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Iarushkina NI; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1287-96. PubMed ID: 25665407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.
    Kash TL; Winder DG
    Neuropharmacology; 2006 Oct; 51(5):1013-22. PubMed ID: 16904135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.
    Ren W; Palazzo E; Maione S; Neugebauer V
    Neuropharmacology; 2011 Dec; 61(8):1334-44. PubMed ID: 21854791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain.
    Neugebauer V; Li W
    J Neurophysiol; 2003 Feb; 89(2):716-27. PubMed ID: 12574449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR2B receptor blockade inhibits pain-related sensitization of amygdala neurons.
    Ji G; Horváth C; Neugebauer V
    Mol Pain; 2009 Apr; 5():21. PubMed ID: 19400952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
    Takahashi C; Ohata H; Shibasaki T
    Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.
    Varodayan FP; Correia D; Kirson D; Khom S; Oleata CS; Luu G; Schweitzer P; Roberto M
    Neuropharmacology; 2017 Oct; 125():418-428. PubMed ID: 28807676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.